New Delhi: The union health minister Mansukh Mandaviya on Friday unveiled the National Medical Devices Policy, 2023, and launched the Export Promotion Council for Medical Devices along with Assistance for Medical Devices clusters for Common Facilities (AMD-CF). This scheme aims to establish and strengthen common infrastructure facilities in the medical devices clusters and fortify testing facilities for medical devices.
While inaugurating the 8 International Conference on Pharma and Medical Device Sector, Mandaviya said, “India’s pharmaceutical industry is robust, resilient and responsive. It is due to this that we could not only meet our own demand during the pandemic, but also be in a position to supply medicines to 150 countries.”
This conference was organized by the Department of Pharmaceuticals in association with Federation of Indian Chambers of Commerce and Industry (FICCI) for two days to promote India as a manufacturing hub of quality medical products in the pharmaceutical and Medical Device Sector.
Declared as a sunrise sector, the Health Minister emphasized that this is an emerging manufacturing hub that has seen phenomenal progress with the implementation of production linked incentive schemes and investments for medical drug parks. Our competitive advantage over other nations is price competitiveness and quality. He further added “if we are to continue being ‘Pharmacy of the World’, there can be no laxity with the quality of our pharmaceutical products, our products should also be affordable and competitive in the global market.”
Highlighting the immense potential of this sector, Mandaviya stated “India’s pharmaceutical sector, called as the Pharmacy of the World, will be contributing more in the coming years for the domestic needs and to cater to global demand too.”
He also focused on the investments in research and development, building efficient manufacturing capacities along with creating ample opportunities for innovation that support a vibrant ecosystem for this sector.
